Journal
CHEST
Volume 135, Issue 6, Pages 1651-1664Publisher
ELSEVIER SCIENCE BV
DOI: 10.1378/chest.08-2830
Keywords
-
Categories
Ask authors/readers for more resources
Thrombocytopenia following heparin administration can be associated with in immune reaction, now referred to as heparin-induced thrombocytopenia (HIT). HIT is essentially a prothrombotic disorder mediated by an IgG antiplatelet factor 4/heparin antibody, which induces platelet, endothelial cell, monocyte, and other cellular activation, leading to thrombin generation and thrombotic complications. Indeed, HIT can also be regarded as a serious adverse drug effect. Importantly, HIT can be a life-threatening and limb-threatening condition frequently associated with characteristically severe and extensive thromboembolism (both venous and arterial) rather than with bleeding. This article provides an overview of HIT, with an emphasis on the clinical diagnosis and management. (CHEST2009; 135:1651-1664)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available